Role of NAD+ and mitochondrial sirtuins in cardiac and renal diseases

KA Hershberger, AS Martin, MD Hirschey - Nature Reviews Nephrology, 2017 - nature.com
Nature Reviews Nephrology, 2017nature.com
The coenzyme nicotinamide adenine dinucleotide (NAD+) has key roles in the regulation of
redox status and energy metabolism. NAD+ depletion is emerging as a major contributor to
the pathogenesis of cardiac and renal diseases and NAD+ repletion strategies have shown
therapeutic potential as a means to restore healthy metabolism and physiological function.
The pleotropic roles of NAD+ enable several possible avenues by which repletion of this
coenzyme could have therapeutic efficacy. In particular, NAD+ functions as a co-substrate in …
Abstract
The coenzyme nicotinamide adenine dinucleotide (NAD+) has key roles in the regulation of redox status and energy metabolism. NAD+ depletion is emerging as a major contributor to the pathogenesis of cardiac and renal diseases and NAD+ repletion strategies have shown therapeutic potential as a means to restore healthy metabolism and physiological function. The pleotropic roles of NAD+ enable several possible avenues by which repletion of this coenzyme could have therapeutic efficacy. In particular, NAD+ functions as a co-substrate in deacylation reactions carried out by the sirtuin family of enzymes. These NAD+-dependent deacylases control several aspects of metabolism and a wealth of data suggests that boosting sirtuin activity via NAD+ supplementation might be a promising therapy for cardiac and renal pathologies. This Review summarizes the role of NAD+ metabolism in the heart and kidney, and highlights the mitochondrial sirtuins as mediators of some of the beneficial effects of NAD+-boosting therapies in preclinical animal models. We surmise that modulating the NAD+–sirtuin axis is a clinically relevant approach to develop new therapies for cardiac and renal diseases.
nature.com